O	0	7	Methods	Method	NNS	B-NP

O	8	17	Therefore	Therefore	RB	B-ADVP
O	17	18	,	,	,	O
O	19	21	we	we	PRP	B-NP
O	22	31	developed	develop	VBD	B-VP
O	32	33	a	a	DT	B-NP
O	34	44	reciprocal	reciprocal	JJ	I-NP
O	45	51	system	system	NN	I-NP
O	52	54	of	of	IN	B-PP
O	55	56	a	a	DT	B-NP
B-Cell	57	61	full	full	JJ	I-NP
I-Cell	61	62	-	-	HYPH	I-NP
I-Cell	62	68	length	length	NN	I-NP
I-Cell	69	72	HIV	HIV	NN	I-NP
I-Cell	73	82	packaging	packaging	NN	I-NP
I-Cell	83	87	cell	cell	NN	I-NP
I-Cell	88	92	line	line	NN	I-NP
O	93	96	and	and	CC	O
O	97	98	a	a	DT	B-NP
O	99	108	shortened	shorten	VBN	I-NP
O	109	111	HI	HI	NN	I-NP
O	111	112	-	-	HYPH	O
O	112	117	viral	viral	JJ	B-NP
O	118	125	shuttle	shuttle	NN	I-NP
O	126	132	vector	vector	NN	I-NP
O	132	133	.	.	.	O

O	134	137	The	The	DT	B-NP
O	138	141	Tat	Tat	NN	I-NP
O	141	142	-	-	HYPH	B-NP
O	142	151	deficient	deficient	JJ	I-NP
O	152	161	packaging	packaging	NN	I-NP
O	162	171	construct	construct	NN	I-NP
O	172	174	is	be	VBZ	B-VP
O	175	181	stably	stably	RB	I-VP
O	182	192	integrated	integrate	VBN	I-VP
O	193	195	in	in	IN	B-PP
O	196	197	a	a	DT	B-NP
B-Cell	198	202	VSVG	VSVG	NN	I-NP
I-Cell	202	203	-	-	HYPH	B-NP
I-Cell	203	214	pseudotyped	pseudotype	VBN	I-NP
I-Cell	215	219	cell	cell	NN	I-NP
I-Cell	220	224	line	line	NN	I-NP
O	225	228	and	and	CC	O
O	229	243	transactivated	transactivate	VBN	B-VP
O	244	246	by	by	IN	B-PP
O	247	250	the	the	DT	B-NP
O	251	258	shuttle	shuttle	NN	I-NP
O	259	265	vector	vector	NN	I-NP
O	266	268	by	by	IN	B-PP
O	269	279	expression	expression	NN	B-NP
O	280	282	of	of	IN	B-PP
O	283	289	TATGFP	TATGFP	NN	B-NP
O	290	294	from	from	IN	B-PP
O	295	296	a	a	DT	B-NP
O	297	309	heterologous	heterologous	JJ	I-NP
O	310	318	promoter	promoter	NN	I-NP
O	319	324	which	which	WDT	B-NP
O	325	329	also	also	RB	B-ADVP
O	330	339	indicates	indicate	VBZ	B-VP
O	340	348	positive	positive	JJ	B-NP
B-Cell	349	354	cells	cell	NNS	I-NP
O	354	355	.	.	.	O

O	356	366	Expression	Expression	NN	B-NP
O	367	369	of	of	IN	B-PP
O	370	373	the	the	DT	B-NP
O	374	376	HI	HI	NN	I-NP
O	376	377	-	-	HYPH	O
O	377	382	viral	viral	JJ	B-NP
O	383	392	structure	structure	NN	I-NP
O	393	401	proteins	protein	NNS	I-NP
O	402	404	is	be	VBZ	B-VP
O	405	411	driven	drive	VBN	I-VP
O	412	414	by	by	IN	B-PP
O	415	416	a	a	DT	B-NP
O	417	424	natural	natural	JJ	I-NP
O	425	426	5	5	CD	I-NP
O	426	427	'	'	SYM	I-NP
B-Cellular_component	428	431	LTR	LTR	NN	I-NP
O	432	440	promoter	promoter	NN	I-NP
O	441	444	and	and	CC	O
O	445	446	a	a	DT	B-NP
O	447	448	3	3	CD	I-NP
O	448	449	'	'	SYM	I-NP
O	450	465	polyadenylation	polyadenylation	NN	I-NP
O	466	472	signal	signal	NN	I-NP
O	472	473	,	,	,	O
O	474	481	whereas	whereas	IN	O
O	482	485	the	the	DT	B-NP
B-Cellular_component	486	494	envelope	envelope	NN	I-NP
O	495	505	expression	expression	NN	I-NP
O	506	509	out	out	IN	B-PP
O	510	512	of	of	IN	B-PP
O	513	516	the	the	DT	B-NP
O	517	524	shuttle	shuttle	NN	I-NP
O	525	531	vector	vector	NN	I-NP
O	532	534	is	be	VBZ	B-VP
O	535	543	achieved	achieve	VBN	I-VP
O	544	546	by	by	IN	B-PP
O	547	549	an	an	DT	B-NP
O	550	554	IRES	IRES	NN	I-NP
O	554	555	.	.	.	O

O	556	560	This	This	DT	B-NP
O	561	567	system	system	NN	I-NP
O	568	570	of	of	IN	B-PP
O	571	574	two	two	CD	B-NP
O	575	582	vectors	vector	NNS	I-NP
O	583	585	is	be	VBZ	B-VP
O	586	593	tightly	tightly	RB	B-ADJP
O	594	606	controllable	controllable	JJ	I-ADJP
O	607	610	and	and	CC	O
O	611	619	bypasses	bypass	VBZ	B-VP
O	620	623	the	the	DT	B-NP
O	624	631	problem	problem	NN	I-NP
O	632	634	of	of	IN	B-PP
O	635	642	limited	limited	JJ	B-NP
O	643	652	packaging	packaging	NN	I-NP
O	653	661	capacity	capacity	NN	I-NP
O	662	666	into	into	IN	B-PP
O	667	670	HIV	HIV	NN	B-NP
O	670	671	-	-	HYPH	B-NP
O	671	672	1	1	CD	I-NP
O	673	680	virions	virion	NNS	I-NP
O	680	681	.	.	.	O

